Cosciens Biopharma Inc (CSCIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1999 | 12-1998 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 4,060 | 160 |
| Marketable Securities | 22,010 | 21,270 |
| Receivables | 2,370 | 2,210 |
| Inventories | 780 | 950 |
| Other current assets | 640 | 850 |
| TOTAL | $29,860 | $25,440 |
| Non-Current Assets | ||
| PPE Net | 10,330 | 6,220 |
| Other Non-Current Assets | 800 | 750 |
| TOTAL | $11,130 | $6,970 |
| Total Assets | $40,990 | $32,420 |
| Liabilities | ||
| Current Liabilities | ||
| Short Term Debt | 2,630 | 280 |
| Accounts payable and accrued liabilities | 1,700 | 2,330 |
| TOTAL | $4,330 | $2,620 |
| Non-Current Liabilities | ||
| TOTAL | $N/A | $N/A |
| Total Liabilities | $4,330 | $2,620 |
| Shareholders' Equity | ||
| Common Shares | 40,670 | 31,160 |
| Retained earnings | -4,010 | -1,360 |
| Other shareholders' equity | 0 | -10 |
| TOTAL | $36,660 | $29,790 |
| Total Liabilities And Equity | $40,990 | $32,410 |